Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cheryl A. Abbas
Observed names:
Abbas, Cheryl,
C Abbas,
C. Abbas,
Cheryl Abbas
Institutions:
Novartis (United States),
Kardigan
Observed institutions:
University of the Sciences,
Novartis (Switzerland),
Thomas Jefferson University,
Thomas Jefferson University Hospital,
Novartis (United States),
Novartis (Australia),
Kardigan
show all 7
ORCID:
0000-0002-2594-0862
Observed ORCID:
0000-0002-2594-0862
OpenAlex ID:
A5044768601
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction
2019
·
Akshay S. Desai
, Scott D. Solomon
, et al.
·
JAMA
·
319
PDF
Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
2020
·
Sean P. Murphy
, Margaret F. Prescott
, et al.
·
JACC Heart Failure
·
86
PDF
An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
2024
·
Michael J. Koren
, Fatima Rodriguez
, et al.
·
Journal of the American College of Cardiology
·
81
Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research
2024
·
Pia R Kamstrup
, R Dermot G Neely
, et al.
·
European Journal of Preventive Cardiology
·
48
PDF
Sex-Based Differences in Biomarkers, Health Status, and Reverse Cardiac Remodelling in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/Valsartan
2020
·
Nasrien E. Ibrahim
, Ileana L. Piña
, et al.
·
European Journal of Heart Failure
·
38
PDF
Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan
2020
·
Nasrien E. Ibrahim
, Ileana L. Piña
, et al.
·
Circulation Heart Failure
·
24
Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study
2021
·
Gary F. Mitchell
, Scott D. Solomon
, et al.
·
Circulation Heart Failure
·
13
Lipoprotein(a) levels in a population with clinical atherosclerotic cardiovascular disease in the United States: A subanalysis from the Lp(a)HERITAGE study
2024
·
Michael D. Shapiro
, Tariq M. Haddad
, et al.
·
Journal of clinical lipidology
·
12
PDF
New drugs: Asenapine, iloperidone, and bepotastine besilate
2010
·
Daniel A. Hussar
, Cheryl A. Abbas
·
Journal of the American Pharmacists Association
·
11
Lipoprotein(a) Levels in Population With Established Atherosclerotic Cardiovascular Disease in the United States: a Subanalysis From the Lp(a)heritage Study
2023
·
Michael D. Shapiro
, Tariq Haddad
, et al.
·
Journal of the American College of Cardiology
·
9
LDL-C management with inclisiran plus usual care vs usual care alone in participants with recent acute coronary syndrome: VICTORION-INCEPTION
2025
·
Kirk Knowlton
, Ann Marie Navar
, et al.
·
Journal of clinical lipidology
·
5
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
2023
·
P Orfanos
, X Hu
, et al.
·
European Journal of Cardiovascular Nursing
·
4
PDF
Review of Current Clinical Strategies of Managing Patients With Elevated Lipoprotein(a): Cost-Effectiveness of Lp(a) Testing and Patient Awareness of Lifestyle Changes Through Public Health Policy in Absence of a Targeted Therapy
2024
·
J. Adams
, P. Orfanos
, et al.
·
Heart Lung and Circulation
·
3
PDF
Low‐Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION‐INCEPTION, a Randomized, Controlled, Open‐Label Trial
2026
·
Kirk U. Knowlton
, Ann Marie Navar
, et al.
·
Journal of the American Heart Association
·
2
Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction
2020
·
Sean P. Murphy
, Margaret F. Prescott
, et al.
·
Journal of Cardiac Failure
·
1
Abstract 14392: Effects of Sacubitril-Valsartan Compared With Enalapril on Pulmonary Artery Pressure in Patients With Heart Failure and Reduced Ejection Fraction
2019
·
Akshay S. Desai
, Amil M. Shah
, et al.
·
Circulation
·
1
Effects of Sacubitril-valsartan Compared with Enalapril on Arterial Hemodynamics, Cardiac Remodeling, and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction
2019
·
Akshay S. Desai
, Scott D. Solomon
, et al.
·
Journal of Cardiac Failure
·
1
Low-dose Vitamin K can Improve Warfarin Control in Patients on LVAD Support
2015
·
Daizo Tanaka
, Venessa L. Kotch
, et al.
·
Digital Commons-TMC (Texas Medical Center)
·
1
26-a-18738-acc Direct Activation of Oxidized Soluble Guanylate Cyclase With Ataciguat Blunts Osteogenic Activation and Notch1 Downregulation in 2d and 3d Models of Moderate Calcific Aortic Valve Disease
2026
·
Dilara Batan
, Peipei Li
, et al.
·
Journal of the American College of Cardiology
Abstract 4367120: Impact of Aortic Valve Calcification on Functional Valve Area and Cardiac Structure and Function in a Phase 2 Trial of Ataciguat
2025
·
Hector Michelena
, Philippe Pibarot
, et al.
·
Circulation
Victorion-initiate: Low-density Lipoprotein Cholesterol Goal Attainment and Cumulative Exposure With “inclisiran First” Versus Usual Care in Patients With Atherosclerotic Cardiovascular Disease
2025
·
Fatima Rodriguez
, Michael Koren
, et al.
·
American Journal of Preventive Cardiology
Abstract 4136334: Treatment Satisfaction With an “Inclisiran First” Implementation Strategy Versus Usual Care in Patients With Atherosclerotic Cardiovascular Disease
2024
·
Cara East
, Michael Koren
, et al.
·
Circulation
Abstract 4139440: A 3-Year, Pre-Trial, Real-world Data Analysis of Patients Enrolled in VICTORION-INITIATE: Insights Using Tokenization
2024
·
Fatima Rodriguez
, R Wright
, et al.
·
Circulation
Low-density lipoprotein cholesterol goal attainment with "inclisiran first" versus usual care in patients with atherosclerotic cardiovascular disease
2024
·
F Rodriguez
, M Koren
, et al.
·
European Heart Journal
Lipid goal attainment across baseline socioeconomic and clinical factors comparing an "inclisiran first" implementation strategy and usual care: subgroup analysis of VICTORION-INITIATE
2024
·
M Koren
, F Rodriguez
, et al.
·
European Heart Journal
Show more works
View as search
Works count:
33
Citation count:
659
H-index:
9
I10-index:
9
Year
Topic
Type